Marked synergism between vasopressin and angiotensin II in a human isolated artery

Critical Care Medicine

Volumn 33, Issue 11, 2005, Pages 2613-2620

  Hidaka, Tatewaki ^a   Tsuneyoshi, Isao ^a   Boyle III, Walter A ^b   Onomoto, Masanori ^a   Yonetani, Shin ^a   Hamasaki, Junichirou ^a   Katai, Rumi ^a   Kanmura, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Gastroepiploic artery; Hemorrhagic shock; Human vascular smooth muscle; Tachyphylaxis; Vasopressin

Indexed keywords

ANGIOTENSIN; VASOPRESSIN;

ARTERY; ARTICLE; BLEEDING; BLOOD SAMPLING; CELL MEMBRANE; CONTROLLED STUDY; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; PRIORITY JOURNAL;

EID: 27944431647     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000186759.13325.DC     Document Type: Article

References (34)

1. Tsuneyoshi I, Akata T, Boyle WA: Vascular reactivity. In: Anesthetic Pharmacology: Physiologic Principles and Clinical Practice. A Comparison to Miller's Anesthesia. Evers AS, Maze M (Eds). New York, Churchill Livingstone, 2004, pp 297-321
2. Morales D, Madigan J, Cullinane S, et al: Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 100:226-229
3. Krismer AC, Wenzel V, Stadlbauer KH, et al: Vasopressin during cardiopulmonary resuscitation: A progress report. Crit Care Med 2004; 32(9 Suppl):S432-S435
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
5. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
6. Tsuneyoshi I, Boyle WA: Vasopressin: New uses for an old drug. Contemp Crit Care 2003; 1:1-11
7. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
8. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
9. ++ influx: Role of protein kinase C. J Pharmacol Exp Ther 1992; 261:835-840
10. Prins BA, Weber MA, Purdy RE: Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery. J Pharmacol Exp Ther 1992; 262:198-203
11. Thomas VL, Nielsen MS: Administration of angiotensin II in refractory septic shock. Crit Care Med 1991; 19:1084-1086
12. Yunge M, Petros A: Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82:388-389
13. Coriat P, Richer C, Douraki T, et al: Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81:299-307
14. Medina P, Noguera I, Aldasoro M, et al: Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. Am J Physiol 1997; 272:H1087-H1093
15. Noguera I, Medina P, Segarra G, et al: Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol 1997; 122:431-438
16. Hamu Y, Kanmura Y, Tsuneyoshi I, et al: The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. Anesth Analg 1999; 88:542-548
17. + in vascular smooth muscle cells. Kidney Int 1990; 38:47-54
18. Tsuneyoshi I, Kanmura Y, Yoshimura N: Lipoteichoic acid from Staphylococcus aureus depresses contractile function of human arteries in vitro due to the induction of nitric oxide synthase. Anesth Analg 1996; 82:948-953
19. Tsuneyoshi I, Kanmura Y, Yoshimura N: Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med 1996; 24:1083-1086
20. Tsuneyoshi I, Kanmura Y, Yoshimura N: Methylprednisolone inhibits endotoxin-induced depression of contractile function in human arteries in vitro. Br J Anaesth 1996; 76:251-257
21. Hjelmqvist H, Ullman J, Gunnarsson U, et al: Haemodynamic and humoral responses to repeated hypotensive haemorrhage in conscious sheep. Acta Physiol Scand 1991; 143:55-64
22. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639-672
23. Griendling KK, Ushio-Fukai M, Lassegue B, et al: Angiotensin II signaling in vascular smooth muscle: New concepts. Hypertension 1997; 29:366-373
24. de Haas SL, Wilkinson IB, Boyd JL, et al: Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition. Br J Clin Pharmacol 2002; 53:193-195
25. Kornfeld M, Gutierrez AM, Persson AE, et al: Angiotensin II induces a tachyphylactic calcium response in the rabbit afferent arteriole. Acta Physiol Scand 1997; 160:165-173
26. Anderson KM, Murahashi T, Dostal DE, et al: Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol 1993; 264:C179-C188
27. Harada K, Ohmori M, Kitho Y, et al: Angiotensin II in human veins: Development of rapid desensitization and effect of indomethacin. Clin Exp Pharmacol Physiol 1999; 26:959-963
28. Caramelo C, Okada K, Tsai P, et al: Mechanisms of the vascular effect of pressor hormones. Am J Cardiol 1988; 62:47G-53G
29. Ishida Y, Kawahara Y, Tsuda T, et al: Involvement of MAP kinase activators in angiotensin Il-induced activation of MAP kinases in cultured vascular smooth muscle cells. FEBS Lett 1992; 310:41-45
30. Moulds RF, Worland PJ: Potentiation of human vascular smooth muscle contraction by angiotensin. J Cardiovasc Pharmacol 1980; 2:377-386
31. Peach MJ, Bumpus FM, Khairallah PA: Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther 1969; 167:291-299
32. Purdy RE, Weber MA, Prins BA, et al: Angiotensin II induced amplification of the vasoconstrictor response to norepinephrine and clonidine. Proc West Pharmacol Soc 1987; 30:171-174
33. Ryding J, Heslet L, Hartvig T, et al: Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. Chest 1995; 107:201-203
34. Bond RF, Johnson G: Vascular adrenergic interactions during hemorrhagic shock. Fed Proc 1985; 44:281-289